(Q40091128)

17 September 2017

1 reference

title

Agents for the treatment of heart failure (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

author name string

J. A. Bristol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6136639

12 August 2023

D. B. Evans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6136639

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6136639

12 August 2023

publication date

1 July 1983

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610030304

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610030304

12 August 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Medicinal Research Reviews

12 August 2023

published in

1 reference

17 September 2017

volume

3

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

259-287

1 reference

The current concept for the cardiac glycoside receptor

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Effects of actodigin on the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

In vitro activity of RO363, a beta1-adrenoceptor selective agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Receptors under pressure. An update on baroreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

The cardiovascular pharmacology of 7-propyl-theo-phylline-dopamine (D4975); comparison with dopamine and dobutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Cyclic nucleotides and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Some aspects of the cardiovascular pharmacology of UK 14,275 in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Cardiotonic effect of phthalazinol (EG-626) in the isolated guinea pig myocardium: Mechanical and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Possible mechanism of the dual action of the new polypeptide (anthopleurin-B) from sea anemone in the isolated ileum and taenia caeci of the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Electromechanical effects of anthopleurin-A (AP-A) on rabbit ventricular muscle: influence of driving frequency, calcium antagonists, tetrodotoxin, lidocaine and ryanodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610030304

Strategy for the discovery and development of a positive inotropic agent

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The contractile behavior of the heart and its functional coupling to the circulation

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

New hope for the failing heart

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Myocardial failure

8

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Heart failure: Pathophysiology and treatment

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

14

62

116

Cattell

1938

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Pharmacological Reviews

15

29

187

Akera

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Mechanism of action of therapeutic levels of cardiac glycosides

12 August 2023

17

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Mechanism of action of the cardiac glycosides on the heart

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiac glycoside receptor, (Na+ + K+)ATPase activity and force of contraction in rat heart

12 August 2023

22

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Distribution of cardiac glycosides in heart and brain of dogs and their affinity to the (Na++K+)-ATPase

12 August 2023

23

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Endogenous ligands and modulators of the digitalis receptors: Some candidates

12 August 2023

24

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Digitalis: its place in modern therapy

12 August 2023

26

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Digitalis update

27

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Digitalis in cardiac failure. Do benefits justify risks?

12 August 2023

28

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Long-term digitalis therapy improves left ventricular function in heart failure

12 August 2023

30

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Digitalis glycosides. 2.

31

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Digitalis cardiotoxicity revisited

12 August 2023

32

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

33

197

19

Caldwell

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

34

204

141

Caldwell

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Structure-Activity Relationships of an Aminosugar Cardiac Glycoside, ASI-222 HCl, in the Heart-Lung Preparation of the Dog

12 August 2023

35

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

36

215

198

Cook

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effect of digoxin and amino sugar cardiac glycoside (ASI-222) on plasma antidiuretic hormone activity.

12 August 2023

37

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Electrophysiological and inotropic effects of natural amino-deoxyglyco-cardenolides

12 August 2023

38

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardenolide analogs. An explanation for the unusual properties of AY 22241

12 August 2023

40

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Differentiation of Receptor Systems activated by Sympathomimetic Amines

12 August 2023

43

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding

12 August 2023

46

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the beta-adrenoceptors

12 August 2023

47

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding

12 August 2023

50

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

51

216

210

Kenakin

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

52

219

447

Ruffolo

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Comparative cardiac dynamic effects of dobutamine and isoproterenol in conscious instrumented dogs

12 August 2023

55

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine

12 August 2023

56

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Clinical and Hemodynamic Effects of Dobutamine in Acute Myocardial Infarction with Left Heart Failure

12 August 2023

57

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure

12 August 2023

58

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

59

199

423

Murphy

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Hemodynamic effects of intravenous butopamine in congestive heart failure

12 August 2023

62

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Differentiation of cardiac chronotropic and inotropic effects of ?-adrenoceptor agonists

12 August 2023

64

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Prenalterol, a non-selective β-adrenoceptor ligand with absolute β1-selective partial agonist activity

12 August 2023

65

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Prenalterol is an agonist at β2- as well as at β1-adrenoceptors

12 August 2023

66

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity

12 August 2023

67

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

68

215

266

Manders

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Pharmacokinetic studies in man of the selective beta1-adrenoceptor agonist, prenalterol

12 August 2023

69

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man

12 August 2023

70

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, in man

12 August 2023

71

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Hemodynamic effects of intravenous prenalterol in severe heart failure

12 August 2023

72

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols

12 August 2023

73

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

beta-Adrenoceptor mediated actions of R0363 and (-)-isoprenaline in anaesthetized cats, rats, and rabbits.

12 August 2023

78

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

83

207

410

Moore

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

12 August 2023

84

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure

12 August 2023

85

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

American Heart Journal

87

102

56

Colucci

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses

12 August 2023

88

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Salbutamol in treatment of heart failure

12 August 2023

89

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure

12 August 2023

90

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Pharmacological Reviews

91

24

1

Goldberg

1972

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

92

140

60

McDonald

1963

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Studies on the positive inotropic effect of dopamine in the guinea-pig heart

12 August 2023

93

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The Mode of Direct Action of Dopamine on the Rabbit Heart

12 August 2023

94

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Noninvasive Evaluation of the Effects of Oral Ibopamine (SB 7505) on Cardiac and Renal Function in Patients with Congestive Heart Failure

12 August 2023

96

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

97

210

252

Gorczynski

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Conformational analogs of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides

12 August 2023

98

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 1. Cardiac and pressor/depressor activities

12 August 2023

99

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

New cardiotonic agents: a search for digitalis substitute

12 August 2023

103

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

106

221

775

Endoh

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes

12 August 2023

108

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts

12 August 2023

109

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.

12 August 2023

110

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs

12 August 2023

111

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effects of amrinone on experimental acute myocardial ischaemic injury

12 August 2023

112

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog

12 August 2023

113

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Hemodynamic assessment of amrinone. A new inotropic agent

12 August 2023

115

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Oral amrinone in refractory congestive heart failure

12 August 2023

116

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

12 August 2023

117

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure

12 August 2023

120

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Amrinone and exercise performance in patients with chronic heart failure

12 August 2023

121

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog

12 August 2023

122

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Amrinone metabolism

123

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Investigation of the pharmacodynamics and pharmacokinetics of 2-(2,4-dimethoxyphenyl)-Imidazo-(4,5-b)-pyridine hydrochloride (AR-L 57 CL) in man

12 August 2023

128

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Molecular Pharmacology

129

17

350

Honerjager

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effects of AR-L115 on Contraction and Relaxation of Isolated Mammalian Cardiac Muscle

12 August 2023

133

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiovascular Effects of AR-L115 BS in Conscious Dogs With and Without Chronic Congestive Heart Failure

12 August 2023

135

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

148

22

702

Roebel

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043

12 August 2023

152

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)

12 August 2023

153

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug Development

12 August 2023

157

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Selective Cyclic Nucleotide Phosphodiesterase Inhibitors as Potential Therapeutic Agents

12 August 2023

159

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

British Journal of Pharmacology

12 August 2023

160

60

284p

Alabaster

1977

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Electrophysiological and haemodynamic effects of a new inotropic agent (UK 14275) in the dog

12 August 2023

161

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiovascular effects of a new inotropic drug in dog and normal man

12 August 2023

162

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure

12 August 2023

166

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium and ouabain

12 August 2023

167

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium

12 August 2023

168

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle

12 August 2023

169

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Molecular Pharmacology

171

7

111

Sheppard

1970

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

172

176

174

Osborne

1971

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

173

182

399

Kline

1972

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The influence of volume loading on the inotropic effect of Ro 7-2956

12 August 2023

175

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Inhibition of heart and brain cvclic adenosine 3′,5′-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides

12 August 2023

176

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Synthesis and enzymic and ionotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3',5'-monophosphate

12 August 2023

179

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The effects of adenosine-und guanosine 3?,5?-phosphoric acid benzyl esters on guinea-pig ventricular myocardium

12 August 2023

180

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

185

199

298

Shibata

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

189

207

271

Blair

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

190

205

683

Shibata

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Cardiotonic Effects of Anthopleurin-A, a Polypeptide from a Sea Anemone

12 August 2023

191

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Inhibition of the positive inotropic effect of anthopleurin-A (AP-A) by dantrolene

12 August 2023

192

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Journal of Pharmacology and Experimental Therapeutics

12 August 2023

193

215

479

Hashimoto

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Interaction of the polypeptide cardiac stimulant Anthopleurin-A with H+, Ca2+, and membrane lipids

12 August 2023

195

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effect of cardiotonic polypeptide anthopleurin-A on canine purkinje and ventricular muscle fibers

12 August 2023

196

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Electrical and Mechanical Effects of Anthopleurin-A, a Polypeptide from a Sea Anemone, on Isolated Rabbit Ventricular Muscle Under Conditions of Hypoxia and Glucose-Free Medium

12 August 2023

197

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective

12 August 2023

199

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The role of vasodilator therapy in heart failure

12 August 2023

200

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

12 August 2023

201

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Vasodilator therapy for chronic heart failure

12 August 2023

202

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Progress in Cardiovascular Diseases

12 August 2023

204

volume

24

publication date

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Clinical Therapeutics

206

4

345

Spann

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Physiologic and pharmacologic determinants of vasodilator response: a conceptual framework for rational drug therapy for chronic heart failure

12 August 2023

207

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification

12 August 2023

208

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Effect of prazosin on renal function in congestive heart failure

12 August 2023

209

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Altered prazosin pharmacokinetics in congestive heart failure

12 August 2023

211

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

The cardiovascular effects of trimazosin

12 August 2023

213

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac Failure

12 August 2023

214

1 reference

https://api.crossref.org/works/10.1002/MED.2610030304

12 August 2023

Identifiers

1 reference

release_wul7vkhr5nabxpkuxeisthmuc4

17 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wul7vkhr5nabxpkuxeisthmuc4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference